Patents by Inventor Mats Holmqvist

Mats Holmqvist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES
    Publication number: 20150005320
    Abstract: The invention relates to compounds of formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof wherein X, Y, A, Z, L and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions and immune disorders.
    Type: Application
    Filed: September 27, 2013
    Publication date: January 1, 2015
    Applicant: Synta Pharmaceuticals Corp.
    Inventors: Yu Xie, Mats Holmqvist, Jerome Mahiou, Mitsunori Ono, Lijun Sun, Shoujun Chen, Shijie Zhang, Jun Jiang, Dinesh Chimmanamada, Chih-Yi Yu
  • COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES
    Publication number: 20140107134
    Abstract: The invention relates to compounds of formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof wherein X, Y, A, Z, L and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions and immune disorders.
    Type: Application
    Filed: September 27, 2013
    Publication date: April 17, 2014
    Applicant: Synta Pharmaceuticals Corp.
    Inventors: Yu Xie, Mats Holmqvist, Jerome Mahiou, Mitsunori Ono, Lijun Sun, Shoujun Chen, Shijie Zhang, Jun Jiang, Dinesh Chimmanamada, Chih-Yi Yu
  • Compounds for inflammation and immune-related uses
    Patent number: 8524756
    Abstract: The invention relates to compounds of formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof wherein X, Y, A, Z, L and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions and immune disorders.
    Type: Grant
    Filed: October 16, 2012
    Date of Patent: September 3, 2013
    Assignee: Synta Pharmaceuticals Corp.
    Inventors: Shoujun Chen, Jun Jiang, Hao Li, David A. James, Dinesh Chimmanamada, Christopher Borella, Lijun Sun, Yu Xie, Mats Holmqvist, Jerome Mahiou, Zhiqiang Xia
  • COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES
    Publication number: 20130142831
    Abstract: The invention relates to compounds of formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof wherein X, Y, A, Z, L and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions and immune disorders.
    Type: Application
    Filed: October 16, 2012
    Publication date: June 6, 2013
    Applicant: Synta Pharmaceuticals Corp.
    Inventors: Shoujun Chen, Jun Jiang, Hao Li, David James, Dinesh Chimmanamada, Christopher Borella, Lijun Sun, Yu Xie, Mats Holmqvist, Jerome Mahiou, Zhiqiang Xia
  • Compounds for inflammation and immune-related uses
    Patent number: 8314134
    Abstract: The invention relates to compounds of formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof wherein X, Y, A, Z, L and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions and immune disorders.
    Type: Grant
    Filed: March 5, 2010
    Date of Patent: November 20, 2012
    Assignee: Synta Pharmaceuticals Corp.
    Inventors: Shoujun Chen, Jun Jiang, Hao Li, David James, Dinesh Chimmanamada, Christopher Borella, Lijun Sun, Yu Xie, Mats Holmqvist, Jerome Mahiou, Zhiqiang Xia
  • COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES
    Publication number: 20100311787
    Abstract: The invention relates to compounds of formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof wherein X, Y, A, Z, L and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions and immune disorders.
    Type: Application
    Filed: March 5, 2010
    Publication date: December 9, 2010
    Applicant: Synta Pharmaceuticals Corp.
    Inventors: Shoujun Chen, Jun Jiang, Hao Li, David James, Dinesh Chimmanamada, Christopher Borella, Lijun Sun, Yu Xie, Mats Holmqvist, Jerome Mahiou, Zhi Qiang Xia
  • Compounds for inflammation and immune-related uses
    Patent number: 7709518
    Abstract: The invention relates to compounds of formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof wherein X, Y, A, Z, L and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions and immune disorders.
    Type: Grant
    Filed: September 21, 2005
    Date of Patent: May 4, 2010
    Assignee: Synta Pharmaceuticals Corp.
    Inventors: Shoujun Chen, Jun Jiang, Hao Li, David James, Dinesh Chimmanamada, Christopher Borella, Lijun Sun, Yu Xie, Mats Holmqvist, Jerome Mahiou, Zhi Qiang Xia
  • Compounds for inflammation and immune-related uses
    Publication number: 20070249661
    Abstract: The invention relates to compounds of formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof wherein X, Y, A, Z, L and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions and immune disorders.
    Type: Application
    Filed: September 21, 2005
    Publication date: October 25, 2007
    Applicant: Synta Pharmaceuticals Corp.
    Inventors: Shoujun Chen, Jun Jiang, Hao Li, David James, Dinesh Chimmanamada, Christopher Borella, Lijun Sun, Yu Xie, Mats Holmqvist, Jerome Mahiou, Zhi Xia
  • Method for modulating calcium ion-release-activated calcium ion channels
    Publication number: 20050148633
    Abstract: The invention relates to a method for modulating Ca2+-release-activated Ca2+ channels (CRAC) in a cell by administering to the cell a compound of formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof wherein X, Y, A, Z, L and n are defined herein.
    Type: Application
    Filed: July 22, 2004
    Publication date: July 7, 2005
    Inventors: Yu Xie, Mats Holmqvist, Jerome Mahiou, Mitsunori Ono, Lijun Sun, Shoujun Chen, Shijie Zhang, Jun Jiang, Dinesh Chimmanamada, Andrea Fleig, Chih-Yi Yu
  • Compounds for inflammation and immune-related uses
    Publication number: 20050107436
    Abstract: The invention relates to compounds of formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof wherein X, Y, A, Z, L and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions and immune disorders.
    Type: Application
    Filed: July 22, 2004
    Publication date: May 19, 2005
    Inventors: Yu Xie, Mats Holmqvist, Jerome Mahiou, Mitsunori Ono, Lijun Sun, Shoujun Chen, Shijie Zhang, Jun Jiang, Dinesh Chimmanamada, Chih-Yi Yu
  • Urea injector in exhaust gas turbine housing
    Patent number: 6883308
    Abstract: Vehicle powered by a combustion engine having an exhaust pipe, a turbine housing connected to the exhaust pipe which exhibits an inlet opening, an outlet opening, a chamber located between the inlet opening and outlet opening in which a turbine wheel is rotatably arranged on a rotational shaft which is mounted in bearings in the housing and extends through a through-hole in the chamber. An injector is provided for injecting urea while the combustion engine is in a predetermined operating conditions into exhaust gases generated by the combustion engine.
    Type: Grant
    Filed: December 16, 2002
    Date of Patent: April 26, 2005
    Assignee: Volvo Lastvagnar AB
    Inventors: Lucan Megas, Lennart Zander, Lennart Andersson, Kristin Holmqvist, Mats Holmqvist
  • UREA INJECTOR IN EXHAUST GAS TURBINE HOUSING
    Publication number: 20040103643
    Abstract: Vehicle powered by a combustion engine having an exhaust pipe, a turbine housing connected to the exhaust pipe which exhibits an inlet opening, an outlet opening, a chamber located between the inlet opening and outlet opening in which a turbine wheel is rotatably arranged on a rotational shaft which is mounted in bearings in the housing and extends through a through-hole in the chamber. An injector is provided for injecting urea while the combustion engine is in a predetermined operating conditions into exhaust gases generated by the combustion engine.
    Type: Application
    Filed: December 16, 2002
    Publication date: June 3, 2004
    Applicant: VOLVO LASTVAGNAR AB
    Inventors: Lucas MEGAS, Lennart ZANDER, Mats HOLMQVIST
  • Silo including a device for preventing obstruction to air flow
    Patent number: 5205094
    Abstract: A silo for cereals has a sloped bottom including channels provided on their top sides with passages for the flow of air which is used in order to facilitate emptying the silo through an outlet opening. The passages have a tendency to become clogged by dust present in the cereals causing an obstruction to the flow of air. In order to prevent this, the end wall of each channel located in the vicinity of the outlet opening is provided with an opening for the passage of dust while at the same time limiting the amount of air flow through the opening.
    Type: Grant
    Filed: December 4, 1991
    Date of Patent: April 27, 1993
    Assignee: PM Luft AB
    Inventor: Mats Holmqvist